Tag Archive: Pediatric Preclinical Testing Consortium

Oct 23 2018

Data Release to Enable Smarter Trials for Pediatric Cancer: Q&A With John Maris, MD

With the release of over 200 genomic tumor models spanning 25 different types of childhood cancer, researchers may now have the ability to skip lengthy preclinical work in their development of novel treatments. With funding from Alex’s Lemonade Stand Foundation (ALSF), the Pediatric Preclinical Testing Consortium (PPTC) announced their data sets will now be made available to any qualified academic petitioner — a move that John Maris, MD, oncologist at Children’s Hospital of Philadelphia Cancer Center and principal investigator of the PPTC’s CHOP site, believes is the first of its kind.

Read the rest of this entry >>

Dec 31 2015

Looking Back on the Year of Precision Medicine

PRECISION MEDICINEIn 2016, one million or more volunteers may begin enrolling in one of the largest long-term medical research studies ever planned. It aims to inform future therapies targeted to the molecular, environmental, and behavioral factors that contribute to diverse diseases.

Read the rest of this entry >>

Sep 23 2015

New Research Consortium Aims to Identify Drugs for Pediatric Cancers

The Children’s Hospital of Philadelphia and four other high-profile oncology research programs plus a coordinating center joined the new Pediatric Preclinical Testing Consortium (PPTC) launched by the National Cancer Institute (NCI) to help researchers identify drug candidates for pediatric clinical trials.

Read the rest of this entry >>